# FOSAPREPITANT DIMEGLUMINE
> **NDA210064** · New Drug Application · Sponsor: TEVA PHARMS USA · Approved 2019-09-05
## Drug
- **FDA Application Number:** NDA210064
- **Application type:** New Drug Application
- **Brand name:** FOSAPREPITANT DIMEGLUMINE
- **Generic name:** FOSAPREPITANT
- **Active ingredients:** FOSAPREPITANT DIMEGLUMINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2019-09-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210064)
---
*AI Analytics · CC0 1.0*